MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,781,853 | +49.6% | 33,953 | -5.2% | 0.03% | +47.6% |
| Q2 2020 | $1,191,399 | +27.4% | 35,810 | +4.1% | 0.02% | +5.0% |
| Q1 2020 | $935,408 | +52.7% | 34,390 | +10.8% | 0.02% | +100.0% |
| Q4 2019 | $612,597 | +47.6% | 31,049 | -3.0% | 0.01% | +42.9% |
| Q3 2019 | $414,992 | +6.1% | 32,021 | +1.9% | 0.01% | 0.0% |
| Q2 2019 | $391,241 | -14.3% | 31,425 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $456,605 | +57.1% | 31,425 | +19.3% | 0.01% | +33.3% |
| Q4 2018 | $290,694 | -55.9% | 26,331 | +5.0% | 0.01% | -50.0% |
| Q3 2018 | $659,341 | -99.9% | 25,070 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $512,681,000 | +12.7% | 25,070 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $455,020,000 | +132946.8% | 25,070 | +2.3% | 0.01% | +20.0% |
| Q4 2017 | $342,000 | -61.1% | 24,504 | -48.5% | 0.01% | -16.7% |
| Q3 2017 | $880,000 | +9.5% | 47,570 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $804,000 | +30.5% | 47,570 | +3.0% | 0.01% | +50.0% |
| Q1 2017 | $616,000 | -14.8% | 46,177 | -3.8% | 0.00% | -20.0% |
| Q4 2016 | $723,000 | +28.9% | 48,023 | 0.0% | 0.01% | +25.0% |
| Q3 2016 | $561,000 | +8.1% | 48,023 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $519,000 | +22.4% | 48,023 | +4.7% | 0.00% | +33.3% |
| Q1 2016 | $424,000 | -37.7% | 45,882 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $681,000 | +2.6% | 45,882 | +13.4% | 0.01% | 0.0% |
| Q3 2015 | $664,000 | -28.1% | 40,470 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $923,000 | +62.5% | 40,470 | +8.3% | 0.01% | +50.0% |
| Q1 2015 | $568,000 | +26.2% | 37,366 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $450,000 | +6.1% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $424,000 | -6.0% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $451,000 | +3.7% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $435,000 | -34.2% | 37,366 | 0.0% | 0.00% | -40.0% |
| Q4 2013 | $661,000 | +22.9% | 37,366 | 0.0% | 0.01% | +25.0% |
| Q3 2013 | $538,000 | -4.4% | 37,366 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $563,000 | – | 37,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |